Galapagos NV
GLPG
#4557
Rank
โ‚น204.84 B
Marketcap
โ‚น3,074
Share price
-1.20%
Change (1 day)
32.88%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น30.87. In 2024 the company made an earnings per share (EPS) of โ‚น106.11 a decrease over its 2023 EPS that were of โ‚น323.06.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-132.67%
2024โ‚น106.11-67.16%
2023โ‚น323.06-199.64%
2022-โ‚น324.2299.03%
2021-โ‚น162.90-68.98%
2020-โ‚น525.18-298.06%
2019โ‚น265.17-554.64%
2018-โ‚น58.32-77.18%
2017-โ‚น255.61-326.21%
2016โ‚น113.00-134.19%
2015-โ‚น330.49-371.34%
2014โ‚น121.80-445.98%
2013-โ‚น35.2032.88%
2012-โ‚น26.49-82.07%
2011-โ‚น147.79-817.9%
2010โ‚น20.5912.73%
2009โ‚น18.26-120.79%
2008-โ‚น87.82-37.67%
2007-โ‚น140.9139.64%
2006-โ‚น100.9128.17%
2005-โ‚น78.736.25%
2004-โ‚น74.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,014-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น341.31-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น217.75-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น188.01-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น665.21-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น487.07-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น343.04-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น55.54 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น112.89-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel